S. Levine

Iva Petkovska, Walter J Koroshetz, Pamela W Schaefer, 2004, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

Factors Associated With Intracerebral Hemorrhage After Thrombolytic Therapy for Ischemic Stroke: Pooled Analysis of Placebo Data From the Stroke-Acute Ischemic NXY Treatment (SAINT) I and SAINT II Trials

Scott E Kasner, D. Tanné, A. Demchuk, 2009, Stroke.

Improved Reliability of the NIH Stroke Scale Using Video Training

T. Brott, B. Tilley, J. Grotta, 1994, Stroke.

Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke

M Frankel, J. Broderick, J. Marler, 1998, Neurology.

Time course of ADCw changes in ischemic stroke: beyond the human eye!

H Soltanian-Zadeh, J P Windham, K. Welch, 1998, Stroke.

Care. A Scientific Statement From the American Heart Association/American A Review of the Evidence for the Use of Telemedicine Within Stroke Systems of

T. Bakas, P. Meyers, R. Holloway, 2009 .

A Review of the Evidence for the Use of Telemedicine Within Stroke Systems of Care: A Scientific Statement From the American Heart Association/American Stroke Association

Brett C Meyer, Philip M Meyers, Lawrence R Wechsler, 2009, Stroke.

AHA/ASA Scientific Statement A Review of the Evidence for the Use of Telemedicine Within Stroke Systems of Care

Lee H. Schwamm, Neale R. Chumbler, Robert G. Holloway, 2009 .

Effects of tissue plasminogen activator for acute ischemic stroke at one year

Joseph P. Broderick, Barbara C. Tilley, J. Broderick, 1999 .

Do gender and race impact the use of antithrombotic therapy in patients with stroke/TIA?

L. Lisabeth, S. Levine, Devin L. Brown, 2004, Neurology.

Recommendations for the implementation of telemedicine within stroke systems of care: a policy statement from the American Heart Association.

Mary G. George, Brett C Meyer, Philip M Meyers, 2009, Stroke.

Acute Ischemic Stroke in Hospitalized Medicare Patients: Evaluation and Treatment

S. Levine, R. Mehta, Patricia L. Baker, 2003, Stroke.

National Stroke Association guidelines for the management of transient ischemic attacks

G. Hankey, R. Sacco, A. Algra, 2006, Annals of neurology.

Guidelines for the Primary Prevention of Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

Seemant Chaturvedi, R. Eckel, L. Appel, 2011, Stroke.

Which Road to Recovery?: Factors Influencing Postacute Stroke Discharge Destinations: A Delphi Study

J. Stein, S. Levine, Ken Cheung, 2021, Stroke.

Disparities in the Use of Intravenous t-PA among Ischemic Stroke Patients: Population-based Recent Temporal Trends.

S. Levine, D. Stefanov, Caroline Cummings, 2019, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Central poststroke pain: A systematic review

S. Levine, Jonathan Singer, Alyssa Conigliaro, 2017, International journal of stroke : official journal of the International Stroke Society.

Managing Ischemic Stroke in Patients Already on Anticoagulation for Atrial Fibrillation: A Nationwide Practice Survey.

H. Kamel, R. Marshall, S. Levine, 2020, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Amino Terminal Pro–B-Type Natriuretic Peptide, Secondary Stroke Prevention, and Choice of Antithrombotic Therapy

R. Kronmal, John L.P. Thompson, S. Levine, 2013, Stroke.

Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials

J. Grotta, M. Kaste, W. Hacke, 2004, The Lancet.

Expansion of Intravenous Tissue Plasminogen Activator Eligibility Beyond National Institute of Neurological Disorders and Stroke and European Cooperative Acute Stroke Study III Criteria.

S. Levine, C. Balucani, Adrian Marchidann, 2015, Neurologic clinics.

The March of Thrombolytic Therapy for Acute Ischemic Stroke to Clinical Trials: Pre-clinical Thrombolysis and Adjuncts to Thrombolysis Research

S. Levine, F. Barone, S. Kazim, 2015 .

Defining Clinically Relevant Cerebral Hemorrhage After Thrombolytic Therapy for Stroke: Analysis of the National Institute of Neurological Disorders and Stroke Tissue-Type Plasminogen Activator Trials

J. Gornbein, J. Saver, S. Levine, 2014, Stroke.

Optimizing an individual's treatment in acute stroke: is a magnetic resonance map leading us towards the holy grail?

S. Levine, 2004, Journal of the Neurological Sciences.

Asymptomatic hemorrhagic transformation of cerebral infarction does not worsen long-term outcome.

J. Grotta, J. Broderick, B. Tilley, 2005, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association).

L. Goldstein, S. Starkman, J. Saver, 2002, Stroke.

Anticoagulants and antiplatelet agents in acute ischemic stroke: Report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a Division of the American Heart Association)

L. Goldstein, S. Starkman, J. Saver, 2002, Neurology.

Clinical Deterioration Following Improvement in the NINDS rt-PA Stroke Trial

J. Grotta, K. Welch, T. Brott, 2001, Stroke.

Validation Assessment of Risk Scores to Predict Postthrombolysis Intracerebral Haemorrhage

D. Tanné, A. Demchuk, S. Kasner, 2011, International journal of stroke : official journal of the International Stroke Society.

The Continued Promise of Neuroprotection for Acute Stroke Treatment.

S. Levine, Shimin Liu, 2008, Journal of experimental stroke & translational medicine.

The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study.

Thomas Brott, Richard Libman, Barbara C Tilley, 2005, Annals of emergency medicine.

Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group.

J. Broderick, J. Marler, B. Tilley, 1999, The New England journal of medicine.

A panoramic, practice-based view of intravenous alteplase 3–4·5 h after stroke

S. Kasner, S. Levine, 2010, The Lancet Neurology.

Selecting Patients for Intra-Arterial Therapy in the Context of a Clinical Trial for Neuroprotection

M. Fisher, Chris Coffey, M. Cudkowicz, 2016, Stroke.

Response to letter regarding article, "defining clinically relevant cerebral hemorrhage after thrombolytic therapy for stroke: analysis of the national institute of neurological disorders and stroke tissue-type plasminogen activator trials".

J. Saver, S. Levine, N. Rao, 2015, Stroke.

Abstract 209: The Most Accurate Definition of Clinically Relevant Hemorrhagic Transformation after Thrombolytic Therapy for Stroke: Analysis of the NINDS-TPA Trials

J. Gornbein, J. Saver, S. Levine, 2012, Stroke.

Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke: A multicenter survey

D. Tanné, J. Binder, P. Karanjia, 1999, Neurology.

Clinical radiologic correlations in acute stroke: is the signal intensity at the end of the tunnel getting brighter quicker?

S. Levine, D. Brown, D. Brown, 2003, Journal of neurology, neurosurgery, and psychiatry.

Informed Consent for Intravenous Tissue Plasminogen Activator in New York State Designated Stroke Centers.

C. Benesch, S. Levine, S. Cole, 2017, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke: a multicenter survey. The t-PA Stroke Survey Group.

D. Tanné, J. Binder, P. Karanjia, 1999, Neurology.

HandiStroke: a handheld tool for the emergent evaluation of acute stroke patients.

S. Levine, K. Baumlin, M. Bessette, 2003, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

NeuroThera Effectiveness and Safety Trial 3: how do we align corporate and scientific integrity to complete and report pharma-sponsored trials properly?

S. Levine, M. Hill, 2014, Stroke.

Stroke trials: What have we learned?

S. Levine, B. Jacobs, R. Madhavan, 2002, Neurological research.

Thrombolytic therapy for stroke: the new paradigm.

S. Levine, 1997, Hospital practice.

Effect of nimodipine on blood pressure in acute ischemic stroke in humans.

F. Gengo, W. Kinkel, S. Levine, 1988, Stroke.

Covering all the bases to improve acute stroke care

S. Levine, 2015, The Lancet Neurology.

Time of day, outcome, and response to thrombolytic therapy: the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Trial experience.

S. Levine, P. Lyden, W. Coplin, 2010, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Heisenberg uncertainty principle Telestroke, QALYs, and current health care policy : The

S. Levine, S. Rudolph, 2011 .

Hospital surveillance of acute stroke treatment in Michigan.

J. Janisse, S. Levine, M. Reeves, 2004, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke-Full Dose Regimen (CLEAR-FDR Stroke Trial)

J. Broderick, A. Pancioli, S. Levine, 2015 .

Combined Approach to Lysis Utilizing Eptifibatide and Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke–Enhanced Regimen Stroke Trial

Ravi S. Menon, Michael T. Mullen, Eric E. Adelman, 2013, Stroke.

Prehospital Stroke Identification: Factors Associated with Diagnostic Accuracy.

S. Levine, R. Sinert, Mohit Sharma, 2015, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Prehospital stroke scales in urban environments

S. Levine, R. Sinert, Mohit Sharma, 2014, Neurology.

Review, Historical Context, and Clarifications of the NINDS rt-PA Stroke Trials Exclusion Criteria: Part 1 Rapidly Improving Stroke Symptoms

J. Grotta, S. Kasner, J. Broderick, 2013, Stroke.

Pre-Clinical Testing of Thrombolytic Therapy for Stroke

S. Levine, A. Guyot, 2001 .

Pilot and Preliminary Studies of Thrombolytic Therapy for Stroke

S. Levine, P. Lyden, E. Haley, 2015 .

Stroke: Support for IV tPA in ischaemic stroke in elderly people

S. Levine, Susan W Law, 2016, Nature Reviews Neurology.

Preclinical Testing of Thrombolytic Therapy for Acute Ischemic Stroke

S. Levine, 2005 .

Hemostatic Activation and Outcome After Recombinant Tissue Plasminogen Activator Therapy for Acute Ischemic Stroke

D. Tanné, R. Macko, B. Tilley, 2006, Stroke.

Acute stroke in the field

J. Switzer, S. Levine, 2016, Neurology.

Effect of Intravenous Recombinant Tissue Plasminogen Activator on Ischemic Stroke Lesion Size Measured by Computed Tomography

S. Levine, 2000 .

Telestroke, QALYs, and current health care policy

S. Levine, S. Rudolph, 2011, Neurology.

The Management of Stroke in Antiphospholipid Syndrome

S. Levine, K. Panichpisal, Eduard Rozner, 2012, Current Rheumatology Reports.

Cocaine-associated intracranial hemorrhage

S. Levine, J. Garcìa, S. Levine, 1996, Neurology.

Recombinant tissue plasminogen activator for minor strokes: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience.

Joseph P. Broderick, Scott Hamilton, Suresh C. Patel, 2005, Annals of emergency medicine.

A risk score to predict intracranial hemorrhage after recombinant tissue plasminogen activator for acute ischemic stroke.

D. Tanné, A. Demchuk, S. Kasner, 2008, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Establishing Recommendations for Stroke Systems in the Thrombectomy Era: The Upstate New York Stakeholder Proceedings

I. Brissette, C. Benesch, S. Levine, 2017, Stroke.

Intravenous Thrombolysis for Acute Ischemic Stroke with Prior Stroke and Diabetes: Think Different?

S. Levine, C. Balucani, 2012 .

Relationship between QT interval dispersion in acute stroke and stroke prognosis: a systematic review.

S. Levine, J. Lazar, C. Balucani, 2014, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Streamlining of prehospital stroke management: the golden hour

Klaus Fassbender, J. Grotta, S. Levine, 2013, The Lancet Neurology.

A Web‐Based Interactive Database System for a Transcranial Doppler Ultrasound Laboratory

Michael Sloan, Yuval Roth, S. Levine, 2006, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

Acute stroke care early in the 21(st) century.

S. Levine, M. Gorman, 1999, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Thrombolysis in patients with transient neurologic deficits

J. Broderick, T. Brott, S. Levine, 2001, Neurology.

Is telemedicine the answer for delivering stroke care to rural areas?

S. Levine, C. Amory, Colum F. Amory, 2007, Nature Clinical Practice Neurology.

Coull et al Anticoagulants and Antiplatelet Agents in Acute Ischemic Stroke 1935

L. Goldstein, S. Starkman, J. Saver, 2002 .

Predictors of good outcome after intravenous tPA for acute ischemic stroke

D. Tanné, A. Demchuk, S. Kasner, 2001, Neurology.

Stroke: from observation to intervention

S. Levine, 2013 .

Dosing errors did not have a major impact on outcome in the NINDS t-PA stroke study.

D. Tanné, A. Demchuk, S. Kasner, 2011, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Dosing errors may impact the risk of rt-PA for stroke: the Multicenter rt-PA Acute Stroke Survey.

D. Tanné, A. Demchuk, S. Kasner, 2004, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Antiphospholipid-protein antibodies and acute ischemic stroke in the NINDS rt-PA Stroke Trial

D. Tanné, S. Levine, B. Tilley, 2003, Neurology.

Response to ethical challenges in stroke research

J. Grotta, P. Pepe, J. Rothrock, 1998 .

Potassium depletion as a risk factor for stroke: will a banana a day keep your stroke away?

S. Levine, B. Coull, 2002, Neurology.

"HOW TO" GUIDE FOR CLINICIANS INTERESTED IN BECOMING INVOLVED IN CLINICAL STROKE RESEARCH

S. Levine, David H Adamowicz, K. Johnston, 2008 .

Design, Progress and Challenges of a Double-Blind Trial of Warfarin versus Aspirin for Symptomatic Intracranial Arterial Stenosis

Harry J. Cloft, David S. Liebeskind, Louis R. Caplan, 2003, Neuroepidemiology.

A New Transcranial Doppler Scoring System for Evaluating Middle Cerebral Artery Stenosis

E. Feldmann, S. Levine, N. Zubizarreta, 2019, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

Atypical progressive stroke syndrome associated with oral contraceptives and cigarette use.

A. Young, S. Levine, J. Knake, 1987, Stroke.

Telestroke: Solid support for virtual acute stroke care.

S. Levine, B. Demaerschalk, 2016, Neurology.

To Treat or Not to Treat?: Pilot Survey for Minor and Rapidly Improving Stroke

E. Feldmann, S. Levine, J. Weedon, 2015, Stroke.

Supplemental oxygen delivery to suspected stroke patients in pre hospital and emergency department settings

S. Levine, A. Moskowitz, L. Richardson, 2014, Medical gas research.

Early stroke treatment associated with better outcome: the ninds rt-pa stroke study

J. Grotta, J. Broderick, J. Marler, 2000, Neurology.

A of the Evidence for the Use of Telemedicine Within Stroke Systems of

T. Bakas, L. Schwamm, P. Meyers, 2009 .

Effectiveness of stroke education in the emergency department waiting room.

S. Levine, L. Richardson, M. Brimacombe, 2010, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

The Application of Telemedicine for Stroke

S. Levine, M. Gorman, 1999 .

Intracerebral hemorrhage associated with oral phenylephrine use: a case report and review of the literature.

S. Levine, S. Messé, C. Balucani, 2014, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Antiphospholipid antibodies: pinning risk on a moving target

S. Levine, K. Kirchoff-Torres, 2009, The Lancet Neurology.

Stroke and technology: prescribing mHealth apps for healthcare providers, patients and caregivers – a brief, selected review

S. Levine, Jonathan Singer, 2016 .

Abstract WP243: Identification of Common Confounders in the Prehospital Identification of Stroke in Urban, Underserved Minorities

S. Levine, T. Gropen, Mohit Sharma, 2013, Stroke.

Central post-stroke pain: theories, diagnosis and treatment

S. Levine, Jonathan Singer, 2016 .

Patient characteristics affecting stroke identification by emergency medical service providers in Brooklyn, New York

S. Levine, R. Sinert, Mohit Sharma, 2016, Internal and Emergency Medicine.

Comparison of Large Vessel Occlusion Prediction Scores (S16.004)

S. Levine, S. Martin-Schild, A. Boehme, 2016 .

Thrombolytic therapy of acute ischemic stroke during pregnancy

J. Broderick, L. Schwamm, S. Starkman, 2006, Neurology.

Magnetic resonance and clinical cerebrovascular disease. An update.

N. Ramadan, S. Levine, R. Deveshwar, 1989, Stroke.

Ischemic Stroke Predictors in Patients Presenting with Dizziness, Imbalance, and Vertigo.

Daohai Yu, S. Levine, C. Balucani, 2018, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

A Policy Statement From the American Heart Association Recommendations for the Implementation of Telemedicine Within Stroke Systems of Care

Mary G. George, D. Goff, M. Kaste, 2013 .

Strokes With Minor Symptoms: An Exploratory Analysis of the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Trials

Pooja Khatri, J. Broderick, E. Jauch, 2010, Stroke.

Cerebrovascular Disease Associated with Antiphospholipid Antibodies

S. Levine, M. Alcauskas, 2010 .

Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association.

P. Wolf, R. Sacco, C. Furberg, 2001, Circulation.

Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association.

P A Wolf, P. Wolf, R. Sacco, 2001, Circulation.

Multiple intracerebral hemorrhages after smoking "crack" cocaine.

S. Levine, S. Levine, K. Kelly, 1990, Stroke.

Vasospasm and thrombus formation as possible mechanisms of stroke related to alkaloidal cocaine.

S. Levine, J. Garcìa, S. Levine, 1995, Stroke.

Olfactory gyrus intracerebral hemorrhage in a patient with COVID-19 infection

S. Levine, Nassim Matin, Sai Si Thu, 2020, Journal of Clinical Neuroscience.

Cerebral hemorrhage following thrombolytic therapy for stroke

S. Levine, L. Roever, 2015, Neurology.

Ataxic hemiparesis: critical appraisal of a lacunar syndrome.

S. Levine, M. Gorman, R. Dafer, 1998, Stroke.

Viewing stroke pathophysiology: an analysis of contemporary methods.

K. Welch, S. Levine, J. Ewing, 1986, Stroke.

Intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older : the tPA stroke survey experience.

D. Tanné, J. Binder, S. Levine, 2000, Stroke.

To Treat or Not to Treat?: Exploring Factors Influencing Intravenous Thrombolysis Treatment Decisions for Minor Stroke

J. Grotta, S. Kasner, J. Broderick, 2018, Stroke.

Utility knife actuator for moving the blade carrier and to release the blade from

Norman Leblanc, Steven R. Levine, Donald A. Brown, 2004 .

Mild stroke and rapidly improving symptoms: it's not always a happy ending.

S. Levine, C. Balucani, 2011, Stroke.

Lack of clinical significance of early ischemic changes on computed tomography in acute stroke.

J. Grotta, K. Welch, S. Levine, 2001, JAMA.

Improved Quality of Stroke Care for Hospitalized Medicare Beneficiaries in Michigan

S. Levine, R. Mehta, Patricia L. Baker, 2005, Stroke.

The role of antiphospholipid antibodies in stroke.

S. Levine, B. Coull, R. Brey, 1992, Neurologic clinics.

A Policy Statement From the American Heart Association Recommendations for the Implementation of Telemedicine Within Stroke

Mary G. George, M. Kaste, P. Gorelick, 2009 .

Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials

Scott Hamilton, Suresh Patel, Joseph P Broderick, 2004, The Lancet.

Finding the Most Powerful Measures of the Effectiveness of Tissue Plasminogen Activator in the NINDS tPA Stroke Trial

J. Grotta, J. Broderick, J. Marler, 2000, Stroke.

Markers of Increased Risk of Intracerebral Hemorrhage After Intravenous Recombinant Tissue Plasminogen Activator Therapy for Acute Ischemic Stroke in Clinical Practice: The Multicenter rt-PA Acute Stroke Survey

Andrew M. Demchuk, D. Tanné, A. Demchuk, 2002, Circulation.

Body Lateropulsion in Stroke: Case Report and Systematic Review of Stroke Topography and Outcome.

S. Levine, M. Rosso, Srinath Ramaswamy, 2021, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Combined Approach to Lysis Utilizing Eptifibatide and Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke-Full Dose Regimen Stroke Trial

J. Broderick, A. Pancioli, S. Levine, 2015, Stroke.

Phase IIB/III Trial of Tenecteplase in Acute Ischemic Stroke: Results of a Prematurely Terminated Randomized Clinical Trial

J. Grotta, G. Levy, S. Levine, 2010, Stroke.

Cerebrovascular disease and pregnancy

S. Levine, J. Lesko, K. Kirchoff-Torres, 2010 .

Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial

J. Broderick, B. Tilley, T. Brott, 2002, Neurology.

Targeting ischemic penumbra: part I - from pathophysiology to therapeutic strategy.

S. Levine, H. Winn, S. Levine, 2010, Journal of experimental stroke & translational medicine.

In Acute Ischemic Stroke, Are Asymptomatic Intracranial Hemorrhages Clinically Innocuous?

L. Price, D. Kent, S. Levine, 2004, Stroke.

Stroke and Etonogestrel/Ethinyl Estradiol Ring (NuvaRing): Clinical, Radiological, and Prognostic Features.

S. Levine, C. Balucani, Z. Adler, 2014, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Apolipoprotein E phenotype and the efficacy of intravenous tissue plasminogen activator in acute ischemic stroke

J. Grotta, J. Broderick, J. Marler, 2001, Annals of neurology.

Stroke education in an emergency department waiting room: a comparison of methods.

S. Levine, L. Richardson, M. Brimacombe, 2015, Health promotion perspectives.

Professionals From the American Heart Association/American Stroke Association Guidelines for the Primary Prevention of Stroke : A Guideline for Healthcare

R. Eckel, L. Appel, V. Howard, 2012 .

Thrombolytic utilization for ischemic stroke in US hospitals with neurology residency program

H. Crystal, S. Levine, H. Valsamis, 2013, Neurology.

Smoking and mortality in stroke survivors: can we eliminate the paradox?

S. Levine, S. Karve, D. Levine, 2014, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Jamaican Susumber Berry Poisoning Mimicking Acute Stroke

S. Levine, M. Rosso, Jonathan Perk, 2022, Cerebrovascular Diseases.

Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke.

R. Sacco, J. Mohr, John L.P. Thompson, 2004, JAMA.

Predicting prognosis after stroke

J. Broderick, B. Tilley, T. Brott, 2000, Neurology.

Early Studies of Thrombolytic Therapy for Stroke

S. Levine, A. Guyot, Luchi Quinones, 2001 .

Editorial Comment aPL and Stroke in Young Women : More Fuel for the Stroke Risk Fire

R. Macko, S. Levine, R. Wityk, 2002 .

Factors Associated With Early Presentation of Acute Stroke

L. Brass, S. Levine, P. Fayad, 1993, Stroke.

Early stroke treatment associated with better outcome: the ninds rt-pa stroke study

J. Grotta, J. Marler, B. Tilley, 2000, Neurology.

Atherosclerotic Peripheral Vascular Disease Symposium II: stroke intervention: state of the art.

R. Felberg, S. Levine, M. Alberts, 2008, Circulation.

A Modified National Institutes of Health Stroke Scale for Use in Stroke Clinical Trials: Preliminary Reliability and Validity

P D Lyden, J. Broderick, T. Brott, 2001, Stroke.

Targeting ischemic penumbra Part II: selective drug delivery using liposome technologies.

H. Winn, S. Levine, Shimin Liu, 2011, Journal of experimental stroke & translational medicine.

Pathophysiology and therapeutic targets for ischemic stroke

S. Levine, 2004, Clinical cardiology.

Ischemic stroke prevention

S. Levine, S. Chaturvedi, S. Hickenbottom, 1999, Current treatment options in neurology.

Recognition and management of stroke in young adults and adolescents

M. Elkind, E. Jauch, J. Biller, 2013, Neurology.

Comparative effectiveness of home blood pressure telemonitoring (HBPTM) plus nurse case management versus HBPTM alone among Black and Hispanic stroke survivors: study protocol for a randomized controlled trial

G. Jean-Louis, J. Teresi, R. Lazar, 2015, Trials.

Teaching NeuroImages: RCVS causing simultaneous convexity subarachnoid hemorrhage and hemimedullary infarction

S. Levine, P. Selvan, 2017, Neurology.

Association of Serial Biochemical Markers With Acute Ischemic Stroke: The National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study

J. Broderick, C. Lindsell, B. Tilley, 2006, Stroke.

Stroke Knowledge and Barriers to Stroke Prevention Among African Americans: Implications for Health Communication

C. Pratt, S. Levine, Louisa Ha, 2003, Journal of health communication.

Systems of Care. A Policy Statement From the American Heart Association Recommendations for the Implementation of Telemedicine Within Stroke

Mary G. George, P. Gorelick, P. Meyers, 2009 .

Independent ischemic stroke risk factors in older Americans: a systematic review

S. Levine, D. Gustafson, Caroline Cummings, 2019, Aging.

Transatlantic Differences in Management of Carotid Stenosis: BRIDGing the Gap in StrokE Management (BRIDGE) Project

J. Grotta, D. Leys, W. Hacke, 2018, The Neurohospitalist.

Is Prehospital Treatment of Acute Stroke too Expensive An Economic Evaluation Based on the First Trial

S. Levine, H. Lossius, K. Fassbender, 2014, Cerebrovascular Diseases.

Mobile Applications for Stroke Prevention: A Survey of Physicians’ Perspectives

S. Levine, C. Balucani, D. Stefanov, 2017 .

Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy.

P D Lyden, M Frankel, D. Tanné, 1999, Stroke.

Medical Mobile Applications for Stroke Survivors and Caregivers.

Abhishek Pandey, S. Levine, C. Balucani, 2015, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Derivation and Validation of the Emergency Medical Stroke Assessment and Comparison of Large Vessel Occlusion Scales.

S. Levine, S. Martin-Schild, A. Boehme, 2017, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Warfarin vs aspirin for symptomatic intracranial stenosis: Subgroup analyses from WASID

S. Kasner, C. Benesch, M. Lynn, 2006, Neurology.

Detection of carotid stenosis in African Americans with ischemic heart disease.

P. Mclaughlin, K. Rajamani, S. Levine, 2006, Journal of vascular surgery.

Intracranial Hemorrhage in COVID-19 Patients

S. Levine, Sanskriti Mishra, E. Stein, 2021, Journal of Stroke and Cerebrovascular Diseases.

Randomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke)

Michael T. Mullen, A. Alexandrov, A. Demchuk, 2017, Stroke.

Effect of Alteplase vs Aspirin on Functional Outcome for PatientsWith Acute Ischemic Stroke andMinor Nondisabling Neurologic Deficits The PRISMS Randomized Clinical Trial

A. Chatterjee, J. Broderick, E. Jauch, 2018 .

Neurologic Improvement in Acute Cerebral Ischemia

R. Conwit, J. Gornbein, D. Liebeskind, 2022, Neurology.

Acute Ischemic Stroke with Very Early Clinical Improvement: A National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Trials Exploratory Analysis.

J. Broderick, J. Saver, S. Levine, 2016, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Rapidly improving stroke symptoms: a pilot, prospective study.

S. Levine, J. Weedon, C. Balucani, 2015, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

The Cost-Effectiveness of Primary Stroke Centers for Acute Stroke Care

S. Levine, D. Boudreau, D. Veenstra, 2012, Stroke.

Intravenous thrombolysis for acute stroke

J. Grotta, J. Marler, T. Brott, 1997, Neurology.

Relation of Antiphospholipid Antibodies to Postmortem Brain Infarcts in Older People

S. Leurgans, D. Bennett, S. Levine, 2015, Circulation.

Hypercoagulable States and Stroke: A Selective Review

S. Levine, 2005, CNS Spectrums.

Prediction of hospital disposition after thrombolysis for acute ischemic stroke using the National Institutes of Health Stroke Scale.

D. Tanné, A. Demchuk, S. Kasner, 2004, Archives of neurology.

Emergency Physician and Stroke Specialist Beliefs and Expectations Regarding Telestroke

S. Levine, A. Moskowitz, J. Bruns, 2009, Stroke.

S. Levine, T. Gropen, M. Szarek, 2014, Prehospital emergency care : official journal of the National Association of EMS Physicians and the National Association of State EMS Directors.

Alteplase for the treatment of acute ischemic stroke in patients with low National Institutes of Health Stroke Scale and not clearly disabling deficits (Potential of rtPA for Ischemic Strokes with Mild Symptoms PRISMS): Rationale and design

A. Chatterjee, J. Broderick, E. Jauch, 2018, International journal of stroke : official journal of the International Stroke Society.

The “almost magical” mobile stroke unit revolution

S. Levine, C. Balucani, 2012, Neurology.

Alteplase for ischaemic stroke—much sooner is much better

Jeffrey L. Saver, J. Saver, S. Levine, 2010, The Lancet.

Lessons from adult stroke trials.

R. Sacco, H. Adams, B. Tilley, 2006, Pediatric neurology.

Does the Magnitude of the Electrocardiogram QT Interval Dispersion Predict Stroke Outcome?

M. Silvestrini, S. Levine, J. Lazar, 2014, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Failure of Antithrombotic Therapy and Risk of Stroke in Patients With Symptomatic Intracranial Stenosis

T. Turan, M. Lynn, S. Levine, 2009, Stroke.